Dr. Fagan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2150 Pennsylvania Ave NW
Washington, DC 20037Phone+1 202-741-3540Fax+1 202-741-2238
Education & Training
- University of ColoradoFellowship, Pulmonary Disease and Critical Care Medicine, 1995 - 1998
- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1992 - 1995
- University of California San Diego School of MedicineClass of 1992
Certifications & Licensure
- DC State Medical License 2024 - 2026
- AL State Medical License 2008 - 2024
- CO State Medical License 1994 - 2015
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program Start of enrollment: 2011 Jun 01
Publications & Presentations
PubMed
- 58 citationsFuture perspectives for the treatment of pulmonary arterial hypertension.Hossein Ardeschir Ghofrani, Robyn J. Barst, Raymond L. Benza, Hunter C. Champion, Karen A. Fagan
Journal of the American College of Cardiology. 2009-06-30 - 172 citationsPulmonary fibrosis and chronic lung inflammation in ET-1 transgenic mice.Berthold Hocher, Anja Schwarz, Karen A. Fagan, Christa Thöne-Reineke, Karim El-Hag
American Journal of Respiratory Cell and Molecular Biology. 2000-07-01 - 202 citationsInhaled Rho kinase inhibitors are potent and selective vasodilators in rat pulmonary hypertension.Tetsutaro Nagaoka, Karen A. Fagan, Sarah A. Gebb, Kenneth G. Morris, Tsutomu Suzuki
American Journal of Respiratory and Critical Care Medicine. 2005-03-01
Press Mentions
- Pulmonary Hypertension Awareness Month Draws Attention to Life-Threatening, Often Misdiagnosed DiseaseOctober 23rd, 2019
- Possible Vaping Related Illness Sends Three Teens in Mobile to HospitalSeptember 13th, 2019
Grant Support
- Grover Conference On Risk Factors In Pulmonary HypertensionNational Heart, Lung, And Blood Institute2011
- Core--AnimalNational Heart, Lung, And Blood Institute2003–2007
- Pulmonary Hypertension Following Intermittent HypoxiaNational Heart, Lung, And Blood Institute2006
- Genetics Of Pulmonary Hypertension In MiceNational Heart, Lung, And Blood Institute2006
- Effects Of Bmprii Mutations In Pulmonary HypertensionNational Heart, Lung, And Blood Institute2006
- 2006 Grover Conference On The Pulmonary Circulation - RHO Family GtpasesNational Heart, Lung, And Blood Institute2006
- Pulmonary Hypertension Following Intermittent HypoxiaNational Heart, Lung, And Blood Institute2003–2006
- PO2 Modulation Of NO And Et1 In Pulmonary HypertensionNational Heart, Lung, And Blood Institute1998–2002
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: